AMANDA LLOYD: Open Payments
NPI 1184173205 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 26 payments from 9 companies in 2025. Trend: 2023 $124 · 2024 $993 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $293 |
| Novo Nordisk Inc | 3 | $158 |
| Lilly USA, LLC | 3 | $58 |
| Alexion Pharmaceuticals, Inc. | 1 | $34 |
| Edwards Lifesciences Corporation | 1 | $33 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: UBRELVY, Wegovy, VRAYLAR, MOUNJARO, STRENSIQ, SAPIEN 3 Ultra RESILIA, SHINGRIX, VOQUEZNA.
Industry payments across MD — which companies pay providers there.
